Higher immune responses were elicited by mRNA-1083 than high-dose quadrivalent inactivated influenza vaccine for all 4 influenza strains and high-dose quadrivalent inactivated influenza vaccine for 3 ...
Since SARS-CoV-2 is here to stay, it is important to assess how our understanding of this virus has changed post-pandemic. Dr. Jamie Guenthoer, a staff scientist in the Overbaugh lab at Fred ...
In a recent observational study published in the journal Immunity, researchers from the United States of America investigated the longevity of antibody responses to severe acute respiratory syndrome ...
In our post-COVID pandemic world, several lingering questions remain pertaining to the culprit, SARS-CoV-2. While we can’t answer the question of, will another SARS-CoV-2 pandemic happen again? We can ...
RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...
Table 1. Severe Acute Respiratory Virus-associated Coronavirus Open Reading Frames Severe acute respiratory syndrome (SARS) caused thousands of human infections worldwide and hundreds of deaths in ...
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...
MIT researchers have delivered a type of vaccine called a particulate vaccine to mice using a virus-mimicking scaffold made from particles of DNA instead of the usual protein particles. It not only ...
mRNA-1083 induced higher immune responses than recommended standard-care influenza and COVID-19 vaccines. (HealthDay News) — mRNA-1083 vaccine is noninferior and induces higher immune responses than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results